Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

The small molecule API market continues to be shaped by cost efficiency and scale-driven manufacturing. Standard APIs dominate due to established synthesis processes and widespread application across ...

(MENAFN- EIN Presswire) EINPresswire/ -- "The synthetic small molecule active pharmaceutical ingredients (APIs) market is characterized by the presence of established pharmaceutical manufacturers, ...